News & Updates

Faecal matter transplantation is quickly transitioning into mainstream medicine with more research and evidence supporting its use.

14 Nov 2022 by

Faecal matter transplantation (FMT) science is maturing and becoming increasingly accepted by the medical community, says an expert.

Faecal matter transplantation is quickly transitioning into mainstream medicine with more research and evidence supporting its use.

14 Nov 2022

Prophylactic gastrostomy improves outcomes in head and neck cancer

13 Nov 2022

Prophylactic percutaneous endoscopic gastrostomy (pPEG) can enhance nutrition outcomes, reduce treatment delay, and maintain quality of life (QoL) in patients with head and neck cancer (HNC), suggests a recent study.

Prophylactic gastrostomy improves outcomes in head and neck cancer

13 Nov 2022

Which endoscopic tool is best at detecting colonic adenoma, polyp?

09 Nov 2022 by

Use of endoscopic assist devices to find any signs of colonic adenoma results in better adenoma detection rate (ADR) and polyp detection rate (PDR) when compared with standard colonoscopy, reports a study, adding that these devices should be widely adopted.

Which endoscopic tool is best at detecting colonic adenoma, polyp?

09 Nov 2022

Is vonoprazan an alternative to pantoprazole in preventing post-EVL ulcers, bleeding?

08 Nov 2022 by

Vonoprazan may be as effective as pantoprazole in reducing the risk of ulcers or bleeding following endoscopic variceal ligation (EVL) in patients with portal hypertension, according to a small study from Egypt presented at the United European Gastroenterology Week (UEG 2022).

Is vonoprazan an alternative to pantoprazole in preventing post-EVL ulcers, bleeding?

08 Nov 2022

One in three Crohn’s disease patients undergo ustekinumab dose intensification

05 Nov 2022

Intensifying the dose of ustekinumab to 4- or 6-weekly is a common recourse among Crohn’s disease (CD) patients, a recent study has found. Patients who had failed prior therapies are more likely to see such intensification.

One in three Crohn’s disease patients undergo ustekinumab dose intensification

05 Nov 2022

Freshwater fish-based diet eases liver steatosis in NAFLD patients

02 Nov 2022 by

Adherence to a freshwater fish-based diet helps regulate the gut microbiota and its metabolites, suggesting benefits in individuals with nonalcoholic fatty liver disease (NAFLD), reveals a study.

Freshwater fish-based diet eases liver steatosis in NAFLD patients

02 Nov 2022

TNF inhibition beyond 24 weeks: How safe in pregnant mums?

02 Nov 2022 by

Continued treatment with tumor necrosis factor (TNF) inhibitors after 24 weeks of pregnancy appears safe and is associated with lower chances of maternal inflammatory bowel disease (IBD) relapse, without increasing adverse neonatal outcomes, new research suggests.

TNF inhibition beyond 24 weeks: How safe in pregnant mums?

02 Nov 2022

Original New Drug Application Approvals by US FDA (16 - 31 October 2022)

02 Nov 2022

New drug applications approved by US FDA as of 16 - 31 October 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 October 2022)

02 Nov 2022

MRI-derived biomarkers pinpoint NASH patients at high risk of progression

31 Oct 2022

The quantitative magnetic resonance imaging (MRI)-derived biomarkers cT1 and liver fat demonstrate good performance for identifying patients with nonalcoholic steatohepatitis (NASH) who have the highest risk of disease progression, as reported in a study.

MRI-derived biomarkers pinpoint NASH patients at high risk of progression

31 Oct 2022

4-percent AET best predictor of PPI discontinuation

28 Oct 2022

An acid exposure time (AET) of 4.0 percent is a reliable prognostic marker of proton pump inhibitor (PPI) therapy discontinuation, a study has shown. In addition, 96 hours of monitoring works better than 48 hours in predicting PPI cessation.

4-percent AET best predictor of PPI discontinuation

28 Oct 2022

News & Updates

Filter by Specialty:

Specialty:

Faecal matter transplantation is quickly transitioning into mainstream medicine with more research and evidence supporting its use.

Faecal matter transplantation is quickly transitioning into mainstream medicine with more research and evidence supporting its use.

Prophylactic gastrostomy improves outcomes in head and neck cancer

Prophylactic gastrostomy improves outcomes in head and neck cancer

Which endoscopic tool is best at detecting colonic adenoma, polyp?

Which endoscopic tool is best at detecting colonic adenoma, polyp?

Is vonoprazan an alternative to pantoprazole in preventing post-EVL ulcers, bleeding?

Is vonoprazan an alternative to pantoprazole in preventing post-EVL ulcers, bleeding?

One in three Crohn’s disease patients undergo ustekinumab dose intensification

One in three Crohn’s disease patients undergo ustekinumab dose intensification

Freshwater fish-based diet eases liver steatosis in NAFLD patients

Freshwater fish-based diet eases liver steatosis in NAFLD patients

TNF inhibition beyond 24 weeks: How safe in pregnant mums?

TNF inhibition beyond 24 weeks: How safe in pregnant mums?

Original New Drug Application Approvals by US FDA (16 - 31 October 2022)

Original New Drug Application Approvals by US FDA (16 - 31 October 2022)

MRI-derived biomarkers pinpoint NASH patients at high risk of progression

MRI-derived biomarkers pinpoint NASH patients at high risk of progression

4-percent AET best predictor of PPI discontinuation

4-percent AET best predictor of PPI discontinuation